ClinicalTrials.Veeva

Menu
C

CNS Healthcare | Clinical Neuroscience Solutions - Orlando

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

SPN-812
TSND-201
Maridebart Cafraglutide
Agomelatine
SPD489
Viloxazine
AR08
Naltrexone
Ferric Carboxymaltose
Sildenafil

Parent organization

This site is a part of CNS Healthcare

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 27 total trials

An Evaluation of the Long-Term Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-EXT)

This study is evaluating the long-term safety and efficacy of TSND-201 in adults with PTSD. Participants that have completed a double-blind clinical...

Invitation-only
Post Traumatic Stress Disorder
Drug: TSND-201

This study is evaluating the safety and efficacy of TSND-201 in adults with PTSD.Eligible participants will enter a 4-week Treatment Period where the...

Enrolling
Post Traumatic Stress Disorder
Drug: Placebo
Drug: TSND-201

The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.

Active, not recruiting
Obesity
Drug: Placebo
Drug: Maridebart Cafraglutide
Status recently updated

The primary objective of this trial is to evaluate the long-term efficacy, safety, and tolerability of maridebart cafraglutide in participants with o...

Not yet enrolling
Enrolling
Overweight
Obesity
Drug: Maridebart cafraglutide
Drug: Placebo

Trial sponsors

Supernus Pharmaceuticals logo
T
Amgen logo
Janssen (J&J Innovative Medicine) logo
Novartis logo
Shire logo
A
A
Alkermes logo
American Regent logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems